Recombinant vaccinia virus expressing human retrovirus gene

Drug – bio-affecting and body treating compositions – Antigen – epitope – or other immunospecific immunoeffector – Virus or component thereof

Patent

Rate now

  [ 0.00 ] – not rated yet Voters 0   Comments 0

Details

4241481, 4241601, 4351723, A61K 3921, A61K 3942, C12N 1500

Patent

active

058493042

ABSTRACT:
A recombinant vaccinia virus capable of expressing HTLV-III envelope protein (env) has been constructed. The expressed env protein is recognized by sera obtained from AIDS patients. The synthesized env protein also produces antibodies when administered to a suitable host, such antibodies having specific binding affinity with the env protein.

REFERENCES:
patent: 4753873 (1988-06-01), Beltz et al.
patent: 4772547 (1988-09-01), Heimer et al.
patent: 4774175 (1988-09-01), Chang et al.
patent: 5017487 (1991-05-01), Stunnenberg et al.
patent: 5081029 (1992-01-01), Zarling
Lizhong et al., Journal of Virology 62: 776-782 (Mar. 1988).
Lifson et al., Nature 323: 725-728 (Oct. 23, 1986).
Sodroski et al., Nature 321:412-417 (May 22, 1986).
Peterlin et al., Proc. Natl. Acad. Sci. USA 83: 9734-9738 (Dec. 1986).
Rosen et al., Nature 319: 555-559 (Feb. 13, 1986).
Langford et al., Molecular and Cellular Biology 6: 3191-3199 (Sep. 1986).
Berman et al., Journal of Virology 62: 3135-3142 (Sep. 1988).
Falkner et al., virology 164: 450-457 (1988).
Earl et al., Aids Research & Human Retroviruses 5(1): 23-32 (1989).
Haigwood et al., J. of Virology 66(1): 172-182 (Jan. 1992).
Hammarskjold et al., J. of Virology 63(5): 1959-1966 (May 1989).
Elango et al., Proc. Natl. Acad. Sci. USA 83:1906-1910 (1986).
Stephens et al., The Embo Journal 5: 237-245 (1986).
Mackett et al., The Embo Journal 4:3229-3234 (1985).
Robey et al., Characterization of Envelope and Core Structural Gene Products of HTLV-III with Sera from AIDS Patients, Science vol. 228, pp. 593-595, see Figure 1, May 1985.
Ratner et al., Complete nucleotide sequence of the AIDS virus, HTLV-III, Nature vol. 313, pp. 277-284, Jan. 1985.
Delente, Glycosylation revisited, Trends in Biotechnology, vol. 3, No. 9, p. 218, 1985.

LandOfFree

Say what you really think

Search LandOfFree.com for the USA inventors and patents. Rate them and share your experience with other people.

Rating

Recombinant vaccinia virus expressing human retrovirus gene does not yet have a rating. At this time, there are no reviews or comments for this patent.

If you have personal experience with Recombinant vaccinia virus expressing human retrovirus gene, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Recombinant vaccinia virus expressing human retrovirus gene will most certainly appreciate the feedback.

Rate now

     

Profile ID: LFUS-PAI-O-1455226

  Search
All data on this website is collected from public sources. Our data reflects the most accurate information available at the time of publication.